Anti-Outer membrane protein C and anti-glycoprotein 2 antibodies in inflammatory bowel disease and their association with complicated forms of Crohn’s disease

[1]  D. Bogdanos,et al.  Crohn’s disease specific pancreatic antibodies: clinical and pathophysiological challenges , 2014, Clinical chemistry and laboratory medicine.

[2]  Dan Knights,et al.  Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.

[3]  Jung Ok Shim,et al.  Gut Microbiota in Inflammatory Bowel Disease , 2013, Pediatric gastroenterology, hepatology & nutrition.

[4]  F. Guarner,et al.  Linking the gut microbiota to human health , 2013, British Journal of Nutrition.

[5]  A. Forbes,et al.  Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn's Disease , 2012, Clinical & developmental immunology.

[6]  Francisco Guarner,et al.  The gut microbiota in IBD , 2012, Nature Reviews Gastroenterology &Hepatology.

[7]  A. Forbes,et al.  Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn’s disease , 2012, BMC Gastroenterology.

[8]  B. Shen.  Bacteriology in the Etiopathogenesis of Pouchitis , 2012, Digestive Diseases.

[9]  C. Preda,et al.  Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease. , 2012, Journal of gastrointestinal and liver diseases : JGLD.

[10]  V. Loening-Baucke,et al.  Mucosal flora in Crohn's disease and ulcerative colitis - an overview. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[11]  I. Dotan.  Disease Behavior in Adult Patients: Are There Predictors for Stricture or Fistula Formation? , 2009, Digestive Diseases.

[12]  C. Büning,et al.  Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn’s disease , 2009, Gut.

[13]  G. Veres,et al.  Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. , 2009, Inflammatory bowel diseases.

[14]  T. Molnár,et al.  New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort , 2008, The American Journal of Gastroenterology.

[15]  J. Belaiche,et al.  Predictors of severe Crohn's disease , 2008, Scandinavian journal of gastroenterology.

[16]  C. O'Morain,et al.  Effect of phenotype on health care costs in Crohn's disease: A European study using the Montreal classification. , 2007, Journal of Crohn's & colitis.

[17]  K. Van Steen,et al.  New serological markers in inflammatory bowel disease are associated with complicated disease behaviour , 2007, Gut.

[18]  M. Vatn,et al.  Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study) , 2007, Scandinavian journal of gastroenterology.

[19]  Shadi Sepehri,et al.  High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease , 2006, Gut.

[20]  S. Cucchiara,et al.  Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease , 2006, Gut.

[21]  R. Baldassano,et al.  Risk factors for initial surgery in pediatric patients with Crohn's disease. , 2006, Gastroenterology.

[22]  Dennis Christie,et al.  Serum Immune Responses Predict Rapid Disease Progression among Children with Crohn's Disease: Immune Responses Predict Disease Progression , 2006, The American Journal of Gastroenterology.

[23]  X. Bossuyt.  Serologic markers in inflammatory bowel disease. , 2006, Clinical chemistry.

[24]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[25]  S. Targan,et al.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. , 2005, Gastroenterology.

[26]  H. Drummond,et al.  Sero-Reactivity to Microbial Components in Crohn's Disease Is Associated with Disease Severity and Progression, but not NOD2/CARD15 Genotype , 2004, The American Journal of Gastroenterology.

[27]  A. Bousvaros,et al.  Serologic Testing with ANCA, ASCA, and Anti-OmpC in Children and Young Adults with Crohn's Disease and Ulcerative Colitis: Diagnostic Value and Correlation with Disease Phenotype , 2004, The American Journal of Gastroenterology.

[28]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[29]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[30]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[31]  Jonathan Braun,et al.  Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. , 2002, Gastroenterology.

[32]  S. Targan,et al.  Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope , 2000, Infection and Immunity.

[33]  D. Bogdanos,et al.  Glycoprotein 2 antibodies in Crohn's disease. , 2013, Advances in clinical chemistry.

[34]  G. Lichtenstein.  New serological markers in inflammatory bowel disease are associated with complicated disease behaviour , 2008 .